🔴 Icecure Medical is trading 8.1% down today, extending its recent seven-session decline

Icecure Medical is trading 8.1% down at $2.23, with no clear company-specific catalyst confirmed for August 24, 2026.

• The recent seven-session decline took shares from $3.00 on August 13 to $2.43 on August 21.
• The company announced a Netherlands distribution agreement with Scovas Medical, but available coverage does not link it to the selloff.
• Broader markets are modestly weaker, though insufficient to clearly explain the move.